Some of the best links we picked up around the internet
Copenhagen-based SNIPR reports today that an experimental CRISPR-armed phage therapy was associated with a remarkable clinical response in a kidney...
With phase 1 data published today in The Lancet Microbe, SNIPR is positioning its experimental CRISPR–Cas-armed phage cocktail, SNIPR001, not simply...